Bain Capital

Bain Capital is a global alternative investment firm specializes in private equity, venture capital, and credit products.

Founded in 1984, they pioneered a consulting-based approach to private equity investing, partnering closely with management teams to offer the insights that challenge conventional thinking, build great businesses and improve operations. Over time, they have organically expanded this approach across asset classes to build one of the strongest alternative asset platforms in the world.

Bain Capital Private Equity pioneered the value-added investment approach. Their globally integrated teams leverage deep vertical expertise and partner with management teams around the world to accelerate growth.

Bain Capital Life Sciences invests in pharmaceutical, biotech, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both  drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs.

Bain Capital has raised a total of $66.8B across 17 funds, their latest being Special Situations Fund. This fund was announced on Jun 7, 2022 and raised a total of $2B across two new venture funds targeting startups of all sizes.

The funds will target investments in fintech, infrastructure, apps and commerce technology. The firm also launched a $560 million fund last year, exclusively targeting crypto-related companies.

Portfolio: Daymon, ATW, ADK, Brillio.